{
  "id": "eb89fe2c6f20dda0",
  "title": "Pricing , Information , And Risk In Pharma \u2013 OpEd",
  "description": "20260214T020000Z",
  "content": "",
  "source": "eurasiareview.com",
  "source_url": "https://www.eurasiareview.com/13022026-pricing-information-and-risk-in-pharma-oped/",
  "published_at": "20260214T020000Z",
  "fetched_at": "2026-02-15T00:30:56.287245+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.eurasiareview.com/13022026-pricing-information-and-risk-in-pharma-oped/",
    "url_mobile": "",
    "title": "Pricing , Information , And Risk In Pharma \u2013 OpEd",
    "seendate": "20260214T020000Z",
    "socialimage": "https://www.eurasiareview.com/wp-content/uploads/2026/01/a-330.jpeg",
    "domain": "eurasiareview.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}